Cargando…

Apoptosis inhibitors and mini-agrin have additive benefits in congenital muscular dystrophy mice

Mutations in LAMA2 cause a severe form of congenital muscular dystrophy, called MDC1A. Studies in mouse models have shown that transgenic expression of a designed, miniaturized form of the extracellular matrix molecule agrin (‘mini-agrin’) or apoptosis inhibition by either overexpression of Bcl2 or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meinen, Sarina, Lin, Shuo, Thurnherr, Raphael, Erb, Michael, Meier, Thomas, Rüegg, Markus A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	WILEY-VCH Verlag 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377088/ https://www.ncbi.nlm.nih.gov/pubmed/21674808 http://dx.doi.org/10.1002/emmm.201100151

Ejemplares similares

Angiotensin II type 1 receptor antagonists alleviate muscle pathology in the mouse model for laminin-α2-deficient congenital muscular dystrophy (MDC1A)
por: Meinen, Sarina, et al.
Publicado: (2012)

Linker molecules between laminins and dystroglycan ameliorate laminin-α2–deficient muscular dystrophy at all disease stages
por: Meinen, Sarina, et al.
Publicado: (2007)

Amelioration of Muscle and Nerve Pathology in LAMA2 Muscular Dystrophy by AAV9-Mini-Agrin
por: Qiao, Chunping, et al.
Publicado: (2018)

Improving Reproducibility of Phenotypic Assessments in the DyW Mouse Model of Laminin-α2 Related Congenital Muscular Dystrophy
por: Willmann, Raffaella, et al.
Publicado: (2017)

Increasing Agrin Function Antagonizes Muscle Atrophy and Motor Impairment in Spinal Muscular Atrophy
por: Boido, Marina, et al.
Publicado: (2018)

Fukuyama Congenital Muscular Dystrophy
por: Agarwal, Amit, et al.
Publicado: (2022)

Fatigue and Muscle Atrophy in a Mouse Model of Myasthenia Gravis Is Paralleled by Loss of Sarcolemmal nNOS
por: Meinen, Sarina, et al.
Publicado: (2012)

Diagnostic approach to the congenital muscular dystrophies
por: Bönnemann, Carsten G., et al.
Publicado: (2014)

Agrin Binds to the Nerve–Muscle Basal Lamina via Laminin
por: Denzer, Alain J., et al.
Publicado: (1997)

Congenital Muscular Dystrophies: A Brief Review
por: Bertini, Enrico, et al.
Publicado: (2011)

Congenital muscular dystrophy with inflammation: Diagnostic considerations
por: Konkay, Kaumudi, et al.
Publicado: (2016)

Congenital muscular dystrophy: from muscle to brain
por: Falsaperla, Raffaele, et al.
Publicado: (2016)

Genetic and Clinical Advances of Congenital Muscular Dystrophy
por: Fu, Xiao-Na, et al.
Publicado: (2017)

Efficacy of steroid therapy for Fukuyama congenital muscular dystrophy
por: Murakami, Terumi, et al.
Publicado: (2021)

The heparan sulfate proteoglycan agrin contributes to barrier properties of mouse brain endothelial cells by stabilizing adherens junctions
por: Steiner, Esther, et al.
Publicado: (2014)

Novel LG1 Mutations in Agrin Causing Congenital Myasthenia Syndrome
por: Xia, Ping, et al.
Publicado: (2021)

Nerve pathology is prevented by linker proteins in mouse models for LAMA2-related muscular dystrophy
por: Reinhard, Judith R, et al.
Publicado: (2023)

Agrin drives synaptogenesis
por: Tuma, Rabiya S.
Publicado: (2005)

Agrin at CNS synapses
por: Dove, Alan W.
Publicado: (2003)

Experiences of Women Who Have Had Carrier Testing for Duchenne Muscular Dystrophy and Becker Muscular Dystrophy During Adolescence
por: Fraser, Harry G., et al.
Publicado: (2018)

Mesoangioblast delivery of miniagrin ameliorates murine model of merosin-deficient congenital muscular dystrophy type 1A
por: Domi, Teuta, et al.
Publicado: (2015)

Merosin-negative congenital muscular dystrophy: Report of five cases
por: Incecik, Faruk, et al.
Publicado: (2015)

Importance of Skin Changes in the Differential Diagnosis of Congenital Muscular Dystrophies
por: Yis, Uluç, et al.
Publicado: (2016)

Tendon Extracellular Matrix Alterations in Ullrich Congenital Muscular Dystrophy
por: Sardone, Francesca, et al.
Publicado: (2016)

Management of congenital muscular dystrophies related to defects in the LMNA gene
por: Quijano-Roy, Susana, et al.
Publicado: (2015)

Ullrich Congenital Muscular Dystrophy (UCMD): Clinical and Genetic Correlations
por: BOZORGMEHR, Bita, et al.
Publicado: (2013)

A Mutation Causes MuSK Reduced Sensitivity to Agrin and Congenital Myasthenia
por: Ben Ammar, Asma, et al.
Publicado: (2013)

Novel SEA and LG2 Agrin mutations causing congenital Myasthenic syndrome
por: Xi, Jianying, et al.
Publicado: (2017)

Severe congenital myasthenic syndromes caused by agrin mutations affecting secretion by motoneurons
por: Jacquier, Arnaud, et al.
Publicado: (2022)

Comparison of Experimental Protocols of Physical Exercise for mdx Mice and Duchenne Muscular Dystrophy Patients
por: Hyzewicz, Janek, et al.
Publicado: (2015)

“I have got something positive out of this situation”: psychological benefits of caregiving in relatives of young people with muscular dystrophy
por: Magliano, Lorenza, et al.
Publicado: (2013)

Injection of a Soluble Fragment of Neural Agrin (NT-1654) Considerably Improves the Muscle Pathology Caused by the Disassembly of the Neuromuscular Junction
por: Hettwer, Stefan, et al.
Publicado: (2014)

Fukuyama-type congenital muscular dystrophy and defective glycosylation of α-dystroglycan
por: Saito, Fumiaki, et al.
Publicado: (2011)

Cyclosporine A in Ullrich Congenital Muscular Dystrophy: Long-Term Results
por: Merlini, Luciano, et al.
Publicado: (2011)

The value of respiratory muscle testing in a child with congenital muscular dystrophy
por: Khirani, Sonia, et al.
Publicado: (2014)

Respiratory and cardiac function in congenital muscular dystrophies with alpha dystroglycan deficiency
por: Pane, M., et al.
Publicado: (2012)

Congenital muscular dystrophy type 1A with residual merosin expression
por: Kim, Hyo Jeong, et al.
Publicado: (2014)

LAMA2 Nonsense Variant in an Italian Greyhound with Congenital Muscular Dystrophy
por: Christen, Matthias, et al.
Publicado: (2021)

An Infant with Blended Phenotype of Zellweger Spectrum Disorder and Congenital Muscular Dystrophy
por: Gupta, Priyanka, et al.
Publicado: (2021)

Author Correction: Efficacy of steroid therapy for Fukuyama congenital muscular dystrophy
por: Murakami, Terumi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dbtpgp67ug20dc5vp7bsajucfb